NewsBenzingaLipocine: BPA del tercer trimestre de $(0.08) supera la estimación de $(0.32), ventas de $2.290M superan la estimación de $159.500K Lipocine: BPA del tercer trimestre de $(0.08) supera la estimación de $(0.32), ventas de $2.290M superan la estimación de $159.500K Benzinga 2026.11.05 13:23 (GMT+0) Open on Benzinga Other news RBC Capital Maintains Outperform on Acadia Pharmaceuticals, Raises Price Target to $38 Barclays Maintains Overweight on Coca-Cola Europacific, Raises Price Target to $124 Barclays Maintains Overweight on Charles River, Raises Price Target to $375 RBC Capital Downgrades Fidelity National Info to Sector Perform, Lowers Price Target to $37 Keefe, Bruyette & Woods Maintains Outperform on Willis Towers Watson, Raises Price Target to $397 Zoetis Lifts Annual Outlook While Braces For Cautious Pet Economy
